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Abstract
Background: The overlap in geographical distribution of Plasmodium falciparum malaria and
endemic Burkitt's lymphoma (eBL) – an aggressive Epstein-Barr virus (EBV)-associated B-cell
tumour occurring almost exclusively in the tropics – strongly suggests a link between the two
diseases. It is suspected that the polyclonal B-cell activation in P. falciparum malaria may precipitate
a breakdown in homeostatic T-cell control of EBV-immortalized B-cell proliferation. Previous
studies have suggested that a particular T-cell subset, characterized by expression of Vδ1+ γδ T-cell
receptors, is important for maintaining B-cell homeostasis, both in P. falciparum- exposed
populations and in individuals subject to polyclonal B-cell activation of other aetiology. The
objective of the present study was, therefore, to characterize lymphocyte phenotypes and to
investigate possible differences in T-cell subset composition and activation status in P. falciparum-
exposed Ghanaian children with and without eBL.
Methods: Venous blood samples in heparin from 21 eBL patients (mean age: 7.0 years; range: 3–
11 years), referred to the Burkitt's Tumour Centre at Korle-Bu Teaching Hospital, Accra and 15
healthy, age and sex matched children, were stained with fluorescein isothiocyanate (FITC)-,
phycoerythrin (PE)-, R-phycoerythrin (RPE)- and RPE-Cy5-conjugated antibodies (CD3, CD4,
CD8, CD25, CD69, CD95, HLA-DR, TCR-γδ, Vδ1, Vδ3, Vγ9 and B-cells) and acquired on a flow
cytometer.
Results: A reduction in the proportion of CD3+ cells in eBL patients, due mainly to perturbations
among TCR-γδ+ cells was observed. In contrast, the proportions of CD4+ or CD8+ cells were
relatively unaffected, as were the mean numbers of peripheral blood mononuclear cells.
Conclusion: Selective changes in numbers and activation status of TCR-γδ+ cells occurs in
Ghanaian children with eBL, a pattern which is similar to P. falciparum-induced changes. The data
supports the hypothesis of a regulatory role for Vδ1+ TcR-γδ T-cells in maintaining B-cell
homeostasis and provides insights into the pathogenesis of eBL.
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Epstein-Barr virus (EBV) is a ubiquitous herpes virus that
can infect and immortalize B-cells. In the vast majority of
cases, EBV infection is either subclinical or leads to the
self-limiting lymphoproliferative disorder infectious
mononucleosis (IM). In both cases, there is an eventual
life-long persistence of the virus in the absence of clinical
symptoms, probably due to continuous surveillance of B-
cell proliferation by immuno-regulatory T-cells. However,
EBV is also involved in the pathogenesis of the aggressive
monoclonal B-cell tumour, endemic Burkitt's lymphoma
(eBL), implying that control of EBV-infected B-cell multi-
plication can break down under certain circumstances
[1,2]. Epidemiological evidence suggests that malaria is a
risk factor for eBL, as the geographical distributions of
Plasmodium falciparum malaria and eBL strikingly overlap,
and both diseases mainly affect children, who are also
most susceptible to malaria in areas of intense P. falci-
parum transmission [3]. Furthermore, T-cells from healthy
EBV-positive individuals inhibit spontaneous in vitro pro-
liferation of autologous B-cells, whereas this does not
happen in P. falciparum patients [4]. Finally, malaria is
associated with marked polyclonal B-cell activation,
which in turn increases the likelihood of malignant trans-
formation of EBV-infected B-cells and subsequent devel-
opment of eBL [5].
The nature and mechanisms of the T-cell restriction of
EBV-infected B-cell proliferation remain only partly
understood, not least because the majority of available
studies pre-date detailed knowledge of the T-cell receptors
and other functionally important markers of various T-cell
subsets. More recently, marked differences have been
reported in T-cell composition relating to P. falciparum
exposure, and associated perturbations among children
from endemic areas, who get malaria [6-8]. Thus, frequen-
cies and absolute numbers of TCR-γδ cells, in particular
cells expressing a T-cell receptor composed of a Vδ 1 chain
and γ-chains other than Vγ9, are several-fold higher in
malaria-exposed than in non-exposed individuals, in
whom such cells usually constitute a very minor subset
(<1% of T-cells) [8]. Furthermore, Vδ1+ T-cells may tran-
siently encompass more than a third of circulating T-cells
and show a highly activated phenotype in children with P.
falciparum malaria [8]. Although the function of Vδ 1+ T-
cells remains obscure, several studies have suggested that
this subset is immuno-regulatory and controls multiplica-
tion of activated and EBV-transformed B-cells. On this
basis, the present study was designed to investigate possi-
ble differences in T-cell subset composition and activation
status in P. falciparum-exposed Ghanaian children with and
without eBL. This study presents evidence of selective
changes in numbers and activation status of TCR-γδ+ cells




Included in the study were 21 patients (mean age: 7.0
years; range: 3–11 years) from all parts of Ghana who
were referred to the Burkitt's Tumour Centre at Korle-Bu
Teaching Hospital, Accra with a diagnosis of eBL on the
basis of clinical information and cytological examination
of tumour aspirates by a pathologist. In addition, 15
healthy children, matched for age and sex, from a nearby
community (Dodowa town outside Accra) served as con-
trols. Informed consent was obtained from all parents or
guardians before their children were enrolled in the study.
The Institutional Review Board at Noguchi Memorial
Institute and the University of Ghana Medical School Sci-
entific Research and Ethical Committee both granted eth-
ical approvals for the study.
Blood sample collection and processing
Venous blood samples were collected into sterile 10 ml
heparinized vacutainer tubes using sterile butterfly nee-
dles. Peripheral blood mononuclear cells (PBMC) were
isolated by Lymphoprep (Nycomed Pharma, As, Oslo)
density gradient centrifugation. A volume of 5 ml of
venous blood was carefully layered on top of 2 ml of Lym-
phoprep and centrifuged at 814 g for 30 minutes. The ring
of PBMC was removed and washed three times in RPMI-
1640 containing 10% heat-inactivated foetal calf serum
(FCS) supplemented with gentamycin, and L-glutamine.
Peripheral blood mononuclear cells (PBMC) were cryop-
reserved in liquid nitrogen as described [9].
Parasitological and haematological examinations
An automated haematology analyzer (Sysmex KX-21,
Japan) was used to determine all the 21 haematological
parameters of the patients and the subjects. The absolute
counts of lymphocytes were determined from this analy-
sis. Each blood sample was also examined for presence of
malaria parasites. Thick and thin blood smears were pre-
pared, dried and the thin smears fixed in methanol. The
films were then stained with freshly prepared 10%
Giemsa (Laboratory Supplies, Poole BH15 ITD, England),
washed carefully and thoroughly under running tap
water. The slides were dried and observed with immersion
oil under a light microscope (Olympus BH2, Japan) at
100× magnification, for the presence of P. falciparum par-
asites.
Flow cytometry
On the day of analysis by flow cytometry, the PBMCs were
quickly thawed in a water bath at 37°C, washed in PBS,
adjusted to 1 × 106/ml, and labeled with combinations of
subset- or activation-specific monoclonal antibodies
directly conjugated to fluorescein isothiocyanate (FITC),
phycoerythrin (PE) or PE-Cy5. Antibodies used were
directed against CD3 (UCHT1; DAKO, Glostrup, Den-Page 2 of 5
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CD25 (ACT-1; DAKO), CD69 (L78, Becton Dickinson
(BD) Biosciences), CD95 (DX2; BD Immunocytometry
Systems), HLA-DR (L243; BD Immunocytometry Sys-
tems), TCR-γδ (11F2; BD PharMingen (PE) and 11F2; BD
Immunocytometry Systems (FITC), Vδ1 (TS8.2;
Endogen), Vδ2 (B6; BD PharMingen), Vδ3 (ImmunoTech,
Marseilles, France), Vγ9 (B3; BD PharMingen) and B-cell
(FMC7; DAKO). The PBMC were subsequently washed
once and a minimum of 8,000 forward-and side-scatter
gated mononuclear cells analysed on a FACScan flow
cytometer (Becton Dickinson, Japan).
Statistical analysis
The statistical significance of differences in medians was
calculated by the Mann-Whitney rank-sum test. Confi-
dence intervals for median differences were calculated
using CIA 2.0 software [10]. Values of P < 0.05 were con-
sidered significant.
Results
Frequency of T-cells is lower in eBL patients than in 
healthy controls
The mean frequency of peripheral blood CD3+ cells was
significantly lower in BL patients (66.5 [47.6 to 72.1] than
in healthy controls (81.7 [76.4 to 86.4]), p < 0.001. This
is mainly due to low TCR-γδ+ cell numbers. In contrast, the
proportions of CD4+cells, 63.5 [53.6 to 65.7] for eBL
against 68.0 [57.8 to 75.0] for healthy controls, p = 0.11
or CD8+ cells, 27.8 [26.6 to 31.7] for eBL against 20.9
[16.6 to 29.7] healthy controls, p = 0.08, were relatively
unaffected. (Table 1), as were the mean numbers of
peripheral blood mononuclear cells (eBL patients: 3.2 ×
109/L [95% confidence interval 2.4 to 4.0 × 109/L], con-
trol donors: 3.4 × 109/L; [2.7 to 4.0 × 109/L]; student's t-
test: P = 0.71).
Activation status of T-cells in eBL patients
The frequencies of TCR-γδ+ CD25 and HLA-DR+ were sig-
nificantly higher in eBL patients compared to healthy con-
trols, p = 0.007 and 0.003 respectively. There were no
differences between the two groups with respect to TCR-
γδ+ CD69+ and TCR-γδ+ CD95+ (Table 2). With respect to
TCR-γδ+ cells, the frequency of CD25+ cells was lower in
eBL patients (8.0 [4.9 to 11.1]) compared to the healthy
controls (13.5 [9.3 to 16.9]), p = 0.04.
Discussion
In a previous study, it was reported that frequencies of
TCR-γδ+ cells are selectively increased in P. falciparum-
exposed healthy Ghanaians in general, and in children in
particular [7]. The findings regarding the healthy children
included in the present study are in agreement with the
earlier data (Table 1, left). It has been have further
reported that episodes of P. falciparum malaria among
such children led to marked perturbations in lymphocyte
subset composition, which particularly affected TCR-γδ+
cells [6,8]. Interestingly, the children with eBL studied
here showed changes in lymphocyte composition that
resemble the changes seen in children with P. falciparum
malaria (Table 1). Thus, a marked reduction in the pro-
portion of CD3+ cells in eBL patients was observed, a dif-
ference which appeared to be mainly due to perturbations
among TCR-γδ+ cells (Table 1). In contrast, the propor-
tions of CD4+ or CD8+ cells were relatively unaffected
(Table 1). The mean numbers of peripheral blood mono-
nuclear cells were also unaffected (eBL patients: 3.2 × 109/
L [95% confidence interval 2.4 to 4.0 × 109/L], control
donors: 3.4 × 109/L; [2.7 to 4.0 × 109/L]; student's t-test: P
= 0.71).
In children with P. falciparum malaria, the selective deple-
tion of T-cells and especially of TCR-γδ+ cells [6,11]
appears to be due to the a transient redistribution of acti-
vated T-cells to sites of endothelial inflammation [12,13].
Table 1: Lymphocyte subset frequencies (median percentages [95% confidence intervals]*) in Burkitt's lymphoma patients and healthy 
control donors
Subset Healthy controls eBL patients Difference P(T)*
CD3+** - 81.7 [76.4 to 86.4] 66.5 [47.6 to 72.1] -15.4 [-34.1 to -7.5] <0.001
CD19+** - 0.4 [0.2 to 1.0] 5.8 [4.8 to 8.8] 5.4 [4.2 to 8.4] <0.001
CD3+ CD4+ 63.5 [53.6 to 65.7] 68.0 [57.8 to 75.0] 5.0 [-1.9 to 13.1] 0.11
CD3+ CD8+ 27.8 [26.6 to 31.7] 20.9 [16.6 to 29.7] -6.0 [-11. 5 to 1.8] 0.08
CD3+ TCR-γδ+ 7.5 [4.9 to 15.5] 3.3 [2.6 to 5.4] -3.6 [-7.9 to -1.2] 0.006
TCR-γδ+ Vγ9+ 45.2 [34.8 to 59.8] 18.8 [14.2 to 29.8] -25.2 [-35.4 to -15.1] <0.001
TCR-γδ+ V δ2+ 32.3 [12.3 to 45.1] 9.2 [6.9 to 13.9] -2 1.2 [-3 1.2 to -4.8] 0.007
TCR-γδ+ V δ3+ 7.7 [5.0 to 11. 7] 9.8 [5.4 to 14.3] 2.2 [-1.9 to 6.6] 0.25
TCR-γδ+ CD4+ 4.8 [3.7 to 9.6] 7.5 [4.9 to 34.8] 2.9 [0.1 to 24.2] 0.04
TCR-γδ+ CD8+ 31.2 [26.4 to 48.3] 36.6 [26.0 to 45.9] 0.0 [-8.0 to 11.0] 0.98
* The statistical significance of differences in medians was calculated by the Mann-Whitney rank-sum test. Confidence intervals for median 
differences were calculated using CIA 2.0 software [1].
** Of all lymphocytes identified by forward and side scatter propertiesPage 3 of 5
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ogy as in malaria patients remains speculative. However,
the activation phenotype of the T-cells obtained from the
eBL patients (Table 2) points to selective reallocation of T-
cells – and in particular of TCR-γδ+ cells – as an important
factor behind the observed changes in lymphocyte subset
composition in eBL patients (Table 1). Previous findings
of increased serum levels of soluble IL-2 receptor (CD25)
and soluble ICAM-1 (CD54) in eBL patients [14,15],
which again resembles the situation in P. falciparum
malaria [16], lends further support to this eBL reallocation
hypothesis.
Within the TCR-γδ+ cell compartment, the perturbations
in relation to P. falciparum malaria among children living
in endemic areas are mainly caused by a dramatic increase
in the proportion of γδ T-cells expressing a T-cell receptor
composed of a Vδ1 chain in combination with γ-chains
other than Vγ9 [8]. Although Vδ1+ cells were not directly
examined here, the pronounced reduction in the propor-
tions of the complementary Vγ9+ and Vδ2+ subsets in eBL
patients (Table 1) constitute indirect evidence that the
proportion of Vδ1+ cells is increased in eBL patients as it is
in children with P. falciparum malaria.
Taken together, the data presented here show a remarka-
bly similar impact on peripheral lymphocyte composition
of eBL and P. falciparum malaria, which may reflect a
causal link between the two diseases. The characteristic
massive B-cell activation in P. falciparum malaria [17,18]
appears to compromise homeostatic T-cell control of pro-
liferation of EBV-immortalized B-cells [19]. It is tempting
to speculate that these regulatory T-cells may include Vδ1+
cells, as it has been shown that T-cells belonging to this
subset can recognize and kill activated B-cells [20-22].
Conclusion
Malaria-induced B-cell activation may thus precipitate
malignant transformation of EBV-infected B-cells. Incom-
plete elimination of malignant T-cells due to defects in
auto-regulatory T-cells may subsequently lead to eBL. This
study provides insights regarding the pathogenesis of eBL
and suggests a plausible link between the pathogenesis of
P. falciparum malaria and eBL.
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